150 related articles for article (PubMed ID: 28619275)
1. Differentiation Affects the Release of Exosomes from Colon Cancer Cells and Their Ability to Modulate the Behavior of Recipient Cells.
Lucchetti D; Calapà F; Palmieri V; Fanali C; Carbone F; Papa A; De Maria R; De Spirito M; Sgambato A
Am J Pathol; 2017 Jul; 187(7):1633-1647. PubMed ID: 28619275
[TBL] [Abstract][Full Text] [Related]
2. Post-translational modulation of CD133 expression during sodium butyrate-induced differentiation of HT29 human colon cancer cells: implications for its detection.
Sgambato A; Puglisi MA; Errico F; Rafanelli F; Boninsegna A; Rettino A; Genovese G; Coco C; Gasbarrini A; Cittadini A
J Cell Physiol; 2010 Jul; 224(1):234-41. PubMed ID: 20333645
[TBL] [Abstract][Full Text] [Related]
3. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
[TBL] [Abstract][Full Text] [Related]
4. Exosomal miR-21 promotes proliferation, invasion and therapy resistance of colon adenocarcinoma cells through its target PDCD4.
Sun LH; Tian D; Yang ZC; Li JL
Sci Rep; 2020 May; 10(1):8271. PubMed ID: 32427870
[TBL] [Abstract][Full Text] [Related]
5. Exosomes from BM-MSCs increase the population of CSCs via transfer of miR-142-3p.
Li H; Li F
Br J Cancer; 2018 Sep; 119(6):744-755. PubMed ID: 30220706
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib downregulates CD133 expression through inhibition of the Wnt signaling pathway in colon cancer cells.
Deng Y; Su Q; Mo J; Fu X; Zhang Y; Lin EH
Cancer Invest; 2013 Feb; 31(2):97-102. PubMed ID: 23245395
[TBL] [Abstract][Full Text] [Related]
7. CD133+CD44+ population efficiently enriches colon cancer initiating cells.
Haraguchi N; Ohkuma M; Sakashita H; Matsuzaki S; Tanaka F; Mimori K; Kamohara Y; Inoue H; Mori M
Ann Surg Oncol; 2008 Oct; 15(10):2927-33. PubMed ID: 18663533
[TBL] [Abstract][Full Text] [Related]
8. Roles of CD133 in microvesicle formation and oncoprotein trafficking in colon cancer.
Kang M; Kim S; Ko J
FASEB J; 2019 Mar; 33(3):4248-4260. PubMed ID: 30521383
[TBL] [Abstract][Full Text] [Related]
9. Effects of CD133 Silencing on Survival and Migration of HT-29 Colorectal Cancer Cells.
Akbari M; Shanehbandi D; Asadi M; Shomali N; Faraji A; Khaze V; Pakdel A; Mokhtarzadeh A; Ebrahimi AA; Shabani A; Bardaran B
Iran J Immunol; 2019 Sep; 16(3):246-257. PubMed ID: 31552833
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of platelet-stimulated colon cancer invasion: role of clusterin and thrombospondin 1 in regulation of the P38MAPK-MMP-9 pathway.
Radziwon-Balicka A; Santos-Martinez MJ; Corbalan JJ; O'Sullivan S; Treumann A; Gilmer JF; Radomski MW; Medina C
Carcinogenesis; 2014 Feb; 35(2):324-32. PubMed ID: 24085798
[TBL] [Abstract][Full Text] [Related]
11. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
[TBL] [Abstract][Full Text] [Related]
12. Effect of sodium butyrate on the expression of retinoblastoma (RB1) and P53 gene and phosphorylation of retinoblastoma protein in human colon tumor cell line HT29.
Gope R; Gope ML
Cell Mol Biol (Noisy-le-grand); 1993 Sep; 39(6):589-97. PubMed ID: 8220069
[TBL] [Abstract][Full Text] [Related]
13. Comparison of nucleostemin gene expression in CD133+ and CD133- cell population in colon cancer cell line HT29.
Zia-Jahromi N; Hejazi SH; Panjepour M; Parivar K; Gharagozloo M
J Cancer Res Ther; 2014; 10(1):68-72. PubMed ID: 24762489
[TBL] [Abstract][Full Text] [Related]
14. Identification of Endothelin-1 and NR4A2 as CD133-regulated genes in colon cancer cells.
Puglisi MA; Barba M; Corbi M; Errico MF; Giorda E; Saulnier N; Boninsegna A; Piscaglia AC; Carsetti R; Cittadini A; Gasbarrini A; Sgambato A
J Pathol; 2011 Oct; 225(2):305-14. PubMed ID: 21826669
[TBL] [Abstract][Full Text] [Related]
15. Silencing of CD133 inhibits GLUT1-mediated glucose transport through downregulation of the HER3/Akt/mTOR pathway in colon cancer.
Kim H; Ju JH; Son S; Shin I
FEBS Lett; 2020 Mar; 594(6):1021-1035. PubMed ID: 31736063
[TBL] [Abstract][Full Text] [Related]
16. NOX1 to NOX2 switch deactivates AMPK and induces invasive phenotype in colon cancer cells through overexpression of MMP-7.
Banskota S; Regmi SC; Kim JA
Mol Cancer; 2015 Jun; 14():123. PubMed ID: 26116564
[TBL] [Abstract][Full Text] [Related]
17. Oleic Acid Uptake Reveals the Rescued Enterocyte Phenotype of Colon Cancer Caco-2 by HT29-MTX Cells in Co-Culture Mode.
Berger E; Nassra M; Atgié C; Plaisancié P; Géloën A
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28726765
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of calcium sensing receptor null cells: a highly malignant and drug resistant phenotype of colon cancer.
Singh N; Liu G; Chakrabarty S
Int J Cancer; 2013 May; 132(9):1996-2005. PubMed ID: 23055106
[TBL] [Abstract][Full Text] [Related]
19. Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells.
Hu S; Liu L; Chang EB; Wang JY; Raufman JP
Mol Cancer; 2015 Oct; 14():180. PubMed ID: 26463716
[TBL] [Abstract][Full Text] [Related]
20. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
